Literature DB >> 30965127

Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis.

Xiaozhun Tang1, Xiaoliang Huang2, Duoping Wang1, Ruogu Yan3, Fen Lu1, Chen Cheng1, Yulan Li1, Jian Xu4.   

Abstract

Thyroid cancer is the most common type of endocrine tumor. The TNM classification remains a standard for treatment determination and predicting prognosis in thyroid cancer. The genes modules associated with the progression of papillary thyroid carcinoma (PTC) were not clear. We applied a weighted gene co-expression network analysis (WGCNA) and differential expression analysis to systematically identified co-expressed gene modules and hub genes associated with PTC progression based on The Cancer Genome Atlas (TCGA) PTC transcriptome sequencing data. An independent validation cohort, GSE27155, was used to evaluate the preservation of gene modules. We identified two co-expressed genes modules associated with progression of PTC. Enrichment analysis indicated that the two modules were enriched in angiogenesis and extracellular matrix organization. DCN, COL1A1, COL1A2, COL5A2 and COL3A1 were hub genes in the co-expressed network. We systematically identified co-expressed gene modules and hub genes associated with PTC progression for the first time, which provided insights into the mechanisms underlying PTC progression and some potential targets for the treatment of PTC.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Differentially expressed genes (DEGs); Papillary thyroid carcinoma (PTC); Pathological stage; Weighted gene co-expression network analysis (WGCNA)

Mesh:

Year:  2019        PMID: 30965127     DOI: 10.1016/j.gene.2019.04.017

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis.

Authors:  Yuan Guo; Guochun Lu; Huahui Mao; Shengkun Zhou; Xiangmei Tong; Junfei Wu; Qiang Sun; Hui Xu; Fu Fang
Journal:  Onco Targets Ther       Date:  2020-08-12       Impact factor: 4.147

2.  Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.

Authors:  Han Shuwen; Yang Xi; Da Miao; Xu Jiamin; Zhuang Jing; Gao Weili
Journal:  Dis Markers       Date:  2020-06-16       Impact factor: 3.434

3.  Identification of Hub Genes as Biomarkers Correlated with the Proliferation and Prognosis in Lung Cancer: A Weighted Gene Co-Expression Network Analysis.

Authors:  Xuting Xu; Limin Xu; Huilian Huang; Jing Li; Shunli Dong; Lili Jin; Zhihong Ma; Liqin Li
Journal:  Biomed Res Int       Date:  2020-06-10       Impact factor: 3.411

4.  Identification of the potential biomarkers in patients with glioma: a weighted gene co-expression network analysis.

Authors:  Ting-Yu Chen; Yang Liu; Liang Chen; Jie Luo; Chao Zhang; Xian-Feng Shen
Journal:  Carcinogenesis       Date:  2020-07-10       Impact factor: 4.944

5.  Identification of key genes in hepatitis B associated hepatocellular carcinoma based on WGCNA.

Authors:  Chang Liu; Qinghai Dai; Qian Ding; Min Wei; Xiaohong Kong
Journal:  Infect Agent Cancer       Date:  2021-03-16       Impact factor: 2.965

6.  Identification of four hub genes in venous thromboembolism via weighted gene coexpression network analysis.

Authors:  Guoju Fan; Zhihai Jin; Kaiqiang Wang; Huitang Yang; Jun Wang; Yankui Li; Bo Chen; Hongwei Zhang
Journal:  BMC Cardiovasc Disord       Date:  2021-12-03       Impact factor: 2.298

7.  Identification of prognostic biomarkers for papillary thyroid carcinoma by a weighted gene co-expression network analysis.

Authors:  Kexin Meng; Xiaotian Hu; Guowan Zheng; Chenhong Qian; Ying Xin; Haiwei Guo; Ru He; Minghua Ge; Jiajie Xu
Journal:  Cancer Med       Date:  2022-02-12       Impact factor: 4.711

8.  Comprehensive characterization of pathological stage-related genes of papillary thyroid cancer along with survival prediction.

Authors:  Lei Xu; Feng Liu; Haiyan Li; Menglong Li; Yongmei Xie; Zhihui Li; Yanzhi Guo
Journal:  J Cell Mol Med       Date:  2021-08-02       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.